FDA.reportPublic FDA data

INSULIN LISPRO

Substance profile for UNII GFX7QIS1II, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for INSULIN LISPRO
Structure render from PubChem CID 118984450

Substance Identity#

UNII
GFX7QIS1II
Preferred term
INSULIN LISPRO
Registry number
133107-64-9
Ingredient type
INGREDIENT SUBSTANCE
Chemical structure for INSULIN LISPRO
Structure render from PubChem CID 118984450

Chemical And Database Identifiers#

RxCUI
86009
PubChem
118984450
NCIt
C29123
INN ID
7278

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound118984450pubchem.ncbi.nlm.nih.gov/compound/118984450
RxNorm86009mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=86009
NCI ThesaurusC29123ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29123
FDA Substance Registration SystemGFX7QIS1IIprecision.fda.gov/uniisearch/srs/unii/GFX7QIS1II

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19962
ACTIVE MOIETYThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19962
ACTIVE MOIETYThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19963
ACTIVE INGREDIENTThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19963
ACTIVE MOIETYHUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)2
ACTIVE INGREDIENTHUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)2
ACTIVE INGREDIENTHUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY]49
ACTIVE MOIETYHUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY]49
ACTIVE INGREDIENTHUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY]32
ACTIVE MOIETYHUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY]32
ACTIVE INGREDIENTHUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY ]31
ACTIVE MOIETYHUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY ]31